Business · 02/10/2000Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 76 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) withdrew approval of 76 abbreviated new drug applications (ANDA's) at the request of the application holders, who notified the agency that the drug products were no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →